The role of polyunsaturated fatty acids in the neurobiology of major depressive disorder and suicide risk

被引:7
|
作者
Sublette, M. Elizabeth [1 ,2 ]
Daray, Federico Manuel [3 ,4 ]
Gananca, Licinia [5 ,6 ]
Shaikh, Saame Raza [7 ,8 ]
机构
[1] Columbia Univ, Dept Psychiat, New York, NY 10027 USA
[2] New York State Psychiat Inst & Hosp, Mol Imaging & Neuropathol Area, New York, NY 10032 USA
[3] Univ Buenos Aires, Sch Med, Inst Pharmacol, Buenos Aires, Argentina
[4] Natl Sci & Tech Res Council, Buenos Aires, Argentina
[5] Univ Lisbon, Fac Med, Clin Univ Psiquiatria & Psicol Med, Lisbon, Portugal
[6] Ctr Hosp Univ Lisboa Norte, Dept Psiquiatria & Saude Mental, Lisbon, Portugal
[7] Univ N Carolina, Gillings Sch Global Publ Hlth, Nutr Obes Res Ctr, Dept Nutr, Chapel Hill, NC USA
[8] Univ N Carolina, Sch Med, Chapel Hill, NC USA
关键词
OMEGA-3-FATTY-ACID DOCOSAHEXAENOIC ACID; PIOGLITAZONE ADJUNCTIVE THERAPY; WHITE-MATTER MICROSTRUCTURE; PLACEBO-CONTROLLED TRIAL; LONG-CHAIN OMEGA-3; RED-BLOOD-CELLS; DOUBLE-BLIND; EICOSAPENTAENOIC ACID; FISH-OIL; OXIDATIVE STRESS;
D O I
10.1038/s41380-023-02322-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Long-chain polyunsaturated fatty acids (LC-PUFAs) are obtained from diet or derived from essential shorter-chain fatty acids, and are crucial for brain development and functioning. Fundamentally, LC-PUFAs' neurobiological effects derive from their physicochemical characteristics, including length and double bond configuration, which differentiate LC-PUFA species and give rise to functional differences between n(omega)-3 and n-6 LC-PUFAs. LC-PUFA imbalances are implicated in psychiatric disorders, including major depression and suicide risk. Dietary intake and genetic variants in enzymes involved in biosynthesis of LC-PUFAs from shorter chain fatty acids influence LC-PUFA status. Domains impacted by LC-PUFAs include 1) cell signaling, 2) inflammation, and 3) bioenergetics. 1) As major constituents of lipid bilayers, LC-PUFAs are determinants of cell membrane properties of viscosity and order, affecting lipid rafts, which play a role in regulation of membrane-bound proteins involved in cell-cell signaling, including monoaminergic receptors and transporters. 2) The n-3:n-6 LC-PUFA balance profoundly influences inflammation. Generally, metabolic products of n-6 LC-PUFAs (eicosanoids) are pro-inflammatory, while those of n-3 LC-PUFAs (docosanoids) participate in the resolution of inflammation. Additionally, n-3 LC-PUFAs suppress microglial activation and the ensuing proinflammatory cascade. 3) N-3 LC-PUFAs in the inner mitochondrial membrane affect oxidative stress, suppressing production of and scavenging reactive oxygen species (ROS), with neuroprotective benefits. Until now, this wealth of knowledge about LC-PUFA biomechanisms has not been adequately tapped to develop translational studies of LC-PUFA clinical effects in humans. Future studies integrating neurobiological mechanisms with clinical outcomes may suggest ways to identify depressed individuals most likely to respond to n-3 LC-PUFA supplementation, and mechanistic research may generate new treatment strategies.
引用
收藏
页码:269 / 286
页数:18
相关论文
共 50 条
  • [1] Omega-3 polyunsaturated fatty acids for major depressive disorder
    Su, Kuan-Pin
    Wang, Sheng-Min
    Pae, Chi-Un
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (12) : 1519 - 1534
  • [2] A Revision on the Effectiveness of Omega-3 Polyunsaturated Fatty Acids as Monotherapy in the Treatment of Major Depressive Disorder
    Accinni, Tommaso
    Panfili, Matteo
    Tarsitani, Lorenzo
    Biondi, Massimo
    Pasquini, Massimo
    Maraone, Annalisa
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2022, 2022
  • [3] Low omega-3 polyunsaturated fatty acids predict reduced response to standard antidepressants in patients with major depressive disorder
    Cussotto, Sofia
    Delgado, Ines
    Oriolo, Giovanni
    Kemper, Jonas
    Begarie, Diane
    Dexpert, Sandra
    Sauvant, Julie
    Leboyer, Marion
    Aouizerate, Bruno
    Martin-Santos, Rocio
    Schaefer, Martin
    Capuron, Lucile
    DEPRESSION AND ANXIETY, 2022, 39 (05) : 407 - 418
  • [4] Polyunsaturated fatty acids and suicide risk in mood disorders: A systematic review
    Pompili, Maurizio
    Longo, Lucia
    Dominici, Giovanni
    Serafini, Gianluca
    Lamis, Dorian A.
    Sarris, Jerome
    Amore, Mario
    Girardi, Paolo
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2017, 74 : 43 - 56
  • [5] Omega-3 Fatty Acids in Major Depressive Disorder
    Freeman, Marlene P.
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 : 7 - 11
  • [6] Plasma Omega-3 Polyunsaturated Fatty Acids and Survival in Patients with Chronic Heart Failure and Major Depressive Disorder
    Jiang, Wei
    Oken, Harry
    Fiuzat, Mona
    Shaw, Linda K.
    Martsberger, Carolyn
    Kuchibhatla, Maragatha
    Kaddurah-Daouk, Rima
    Steffens, David C.
    Baillie, Rebecca
    Cuffe, Michael
    Krishnan, Ranga
    O'Connor, Christopher
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2012, 5 (01) : 92 - 99
  • [7] Evaluating the Role of Ketamine/Esketamine in the Management of Major Depressive Disorder with Suicide Risk
    Nikayin, Sina
    Sanacora, Gerard
    CNS DRUGS, 2021, 35 (10) : 1069 - 1079
  • [8] Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder
    Mocking, R. J. T.
    Harmsen, I.
    Assies, J.
    Koeter, M. W. J.
    Ruhe, H. G.
    Schene, A. H.
    TRANSLATIONAL PSYCHIATRY, 2016, 6 : e756 - e756
  • [9] Polyunsaturated fatty acid associations with dopaminergic indices in major depressive disorder
    Sublette, M. Elizabeth
    Galfalvy, Hanga C.
    Hibbeln, Joseph R.
    Keilp, John G.
    Malone, Kevin M.
    Oquendo, Maria A.
    Mann, J. John
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 (03): : 383 - 391
  • [10] Omega-3 Polyunsaturated Fatty Acid (PUFA) Status in Major Depressive Disorder With Comorbid Anxiety Disorders
    Liu, Joanne J.
    Galfalvy, Hanga C.
    Cooper, Thomas B.
    Oquendo, Maria A.
    Grunebaum, Michael F.
    Mann, J. John
    Sublette, M. Elizabeth
    JOURNAL OF CLINICAL PSYCHIATRY, 2013, 74 (07) : 732 - 738